By Marc Ross
Sep 14, 2021
Operators in the nascent cannabis industry have a lot to worry about on a daily basis, but compliance with state and federal environmental laws hasn’t been an issue of concern for most. That needs to change immediately.
By Shane Pennington
Sep 13, 2021
Texas has allowed hemp cultivation and state-based manufacturing, distribution, and retail sale of hemp and consumable hemp products since 2019—but only if the products weren’t intended for smoking. This prohibition on a product with such high value for hemp farmers—and soaring consumer demand—was sure to make waves.
By Emily Hackman
Sep 9, 2021
In the first post of a three-part series focused on California cannabis, we will highlight the impact of the 2021 Budget Trailer Bill and the upcoming end of provisional licensing on California cannabis operators, as well as strategies to reduce delays in new license issuance and annual license transitions.
By Jonathan Cherkoss
Aug 30, 2021
Oregon voters passed two of the nation’s most sweeping drug policy reform measures in U.S. history in 2020, energizing grassroots organizers in Colorado and across the country. What's next for decriminalization and psychedelics reform in Colorado?
By Shawn Hauser
Aug 25, 2021
Recent NDIN notification objections from the FDA give us more insight into the agency's factors differentiating "full spectrum" hemp from CBD.
Commentary and analysis on cannabis, hemp, psychedelics, and other emerging therapies from the attorneys and policy specialists at the nation’s leading cannabis law firm.